Levetiracetam Treatment-Associated Acute Rhabdomyolysis in an Adolescent

Aslan N., Yildizdas D., Huseyinli B., ÖZGÜR HOROZ Ö., GÜL MERT G., EKİNCİ F., ...Daha Fazla

JOURNAL OF PEDIATRIC INTENSIVE CARE, cilt.9, sa.2, ss.139-140, 2020 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 9 Sayı: 2
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1055/s-0039-1700951
  • Dergi Adı: JOURNAL OF PEDIATRIC INTENSIVE CARE
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), EMBASE
  • Sayfa Sayıları: ss.139-140
  • Çukurova Üniversitesi Adresli: Evet

Özet

Etiology of rhabdomyolysis includes hereditary muscle enzyme deficiencies, trauma, viral infections, excessive exercise, hypothyroidism, and medications such as colchicine, lithium, and statins. Several studies have reported that various antiepileptic drugs may induce rhabdomyolysis. Levetiracetam is one of the antiepileptic drugs implicated in the etiology of rhabdomyolysis. Herein, we present a case of rhabdomyolysis in an adolescent treated with levetiracetam. We wanted to draw attention to the increasing trend of levetiracetam-associated rhabdomyolysis frequency in pediatric patients.